Hamilton Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Hamilton Wealth's BMY Position: Q1 2026 in Review
Hamilton Wealth reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, selling an estimated $995K and leaving 87,412 shares worth $5.3M. The position accounts for 1.03% of the portfolio, ranked #27.
Hamilton Wealth first reported a position in BMY in Q2 2019 and has held it in 19 quarters since. The position peaked at $10.1M in Q3 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Hamilton Wealth held 87,412 shares of Bristol-Myers Squibb worth $5.3M as of Q1 2026.
- Hamilton Wealth sold 17,071 Bristol-Myers Squibb shares in Q1 2026, an estimated $995K.
- Bristol-Myers Squibb made up 1.03% of Hamilton Wealth's portfolio in Q1 2026, its #27 holding.
- Hamilton Wealth first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 19 quarters since.
- Hamilton Wealth's Bristol-Myers Squibb position peaked at $10.1M in Q3 2024.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.